Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 2

Sponsor Class

OTHER 86INDUSTRY 14OTHER_GOV 2NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 267Neoplasms 177Colorectal Neoplasms 133Stomach Neoplasms 107Uterine Cervical Neoplasms 96Carcinoma, Non-Small-Cell Lung 89Prostatic Neoplasms 83Lung Neoplasms 78Carcinoma, Hepatocellular 73Rectal Neoplasms 64Ovarian Neoplasms 54Esophageal Neoplasms 53Pancreatic Neoplasms 52Colonic Neoplasms 52Recurrence 43Multiple Myeloma 39Neoplasm Metastasis 38Head and Neck Neoplasms 37Endometrial Neoplasms 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Motor Activity 34Melanoma 33Polycystic Ovary Syndrome 32Lymphoma 32Urinary Bladder Neoplasms 31Leukemia, Myeloid, Acute 30Thyroid Neoplasms 29Small Cell Lung Carcinoma 28Nasopharyngeal Carcinoma 25Lymphoma, Non-Hodgkin 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Diabetes Mellitus, Type 2 × Clear all
NCT05612269 2022-11-10

SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study

Ministry of Health, Saudi Arabia

Unknown
200 enrolled

Diabetes Mellitus, Type 2, Neoplasms

NCT00850798 2010-07-26

The Benefits of Intensive Glycemic Control in Elderly Patients With Type 2 Diabetes

Taipei Veterans General Hospital, Taiwan

Phase NA Unknown
208 enrolled
Endocrine

Diabetes Mellitus, Type 2, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡